9119 POSTER Combination of Pertuzumab and Erlotinib as 2nd-/3rd-Line (2/3L) Treatment for Patients (pts) With Metastatic Non-Small Cell Lung Cancer (NSCLC) – Safety and Anti-Tumour Activity by FDG-PET/CT Imaging Changes
Saved in:
| Title: | 9119 POSTER Combination of Pertuzumab and Erlotinib as 2nd-/3rd-Line (2/3L) Treatment for Patients (pts) With Metastatic Non-Small Cell Lung Cancer (NSCLC) – Safety and Anti-Tumour Activity by FDG-PET/CT Imaging Changes |
|---|---|
| Authors: | Hughes, B., Mileshkin, L., Townley, P., Gitlitz, B., Eaton, K., Mitchell, P., Hicks, R., Loecke, D., Amler, L., Pirzkall, A. |
| Source: | European Journal of Cancer. Sep2011 Supplement 1, Vol. 47, pS629-S629. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 66158335 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 9119 POSTER Combination of Pertuzumab and Erlotinib as 2nd-/3rd-Line (2/3L) Treatment for Patients (pts) With Metastatic Non-Small Cell Lung Cancer (NSCLC) – Safety and Anti-Tumour Activity by FDG-PET/CT Imaging Changes – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Hughes%2C+B%2E%22">Hughes, B.</searchLink><br /><searchLink fieldCode="AR" term="%22Mileshkin%2C+L%2E%22">Mileshkin, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Townley%2C+P%2E%22">Townley, P.</searchLink><br /><searchLink fieldCode="AR" term="%22Gitlitz%2C+B%2E%22">Gitlitz, B.</searchLink><br /><searchLink fieldCode="AR" term="%22Eaton%2C+K%2E%22">Eaton, K.</searchLink><br /><searchLink fieldCode="AR" term="%22Mitchell%2C+P%2E%22">Mitchell, P.</searchLink><br /><searchLink fieldCode="AR" term="%22Hicks%2C+R%2E%22">Hicks, R.</searchLink><br /><searchLink fieldCode="AR" term="%22Loecke%2C+D%2E%22">Loecke, D.</searchLink><br /><searchLink fieldCode="AR" term="%22Amler%2C+L%2E%22">Amler, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Pirzkall%2C+A%2E%22">Pirzkall, A.</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22European+Journal+of+Cancer%22">European Journal of Cancer</searchLink>. Sep2011 Supplement 1, Vol. 47, pS629-S629. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=66158335 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0959-8049(11)72431-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S629 Titles: – TitleFull: 9119 POSTER Combination of Pertuzumab and Erlotinib as 2nd-/3rd-Line (2/3L) Treatment for Patients (pts) With Metastatic Non-Small Cell Lung Cancer (NSCLC) – Safety and Anti-Tumour Activity by FDG-PET/CT Imaging Changes Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hughes, B. – PersonEntity: Name: NameFull: Mileshkin, L. – PersonEntity: Name: NameFull: Townley, P. – PersonEntity: Name: NameFull: Gitlitz, B. – PersonEntity: Name: NameFull: Eaton, K. – PersonEntity: Name: NameFull: Mitchell, P. – PersonEntity: Name: NameFull: Hicks, R. – PersonEntity: Name: NameFull: Loecke, D. – PersonEntity: Name: NameFull: Amler, L. – PersonEntity: Name: NameFull: Pirzkall, A. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: Sep2011 Supplement 1 Type: published Y: 2011 Identifiers: – Type: issn-print Value: 09598049 Numbering: – Type: volume Value: 47 Titles: – TitleFull: European Journal of Cancer Type: main |
| ResultId | 1 |
